2020 annual financial data
Imunon 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -3,123.74%.
Operating income was -18,486,412 USD and net income was -21,483,561 USD.
Operating cash flow was -15,618,676 USD.
Get free Imunon email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 500,000 USD
- Operating income
- -18,486,412 USD
- Net income
- -21,483,561 USD
- Operating cash flow
- -15,618,676 USD